Why consider treatment in China for Chronic Hepatitis B?

China has extensive experience in managing Chronic Hepatitis B due to its high prevalence, with many hospitals offering advanced antiviral therapies like tenofovir alafenamide (TAF) and entecavir at significantly lower costs than in Western countries. Chinese hepatologists often treat large patient volumes, leading to refined expertise in monitoring for HCC through regular ultrasound and alpha-fetoprotein (AFP) screening. Additionally, the country has modern medical facilities that adhere to international treatment guidelines.